← Open Payments lookup

JEFFERY SCHWAB: Open Payments

NPI 1679714299 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$389 in 16 payments from 7 companies in 2025. Trend: 2023 $358 · 2024 $523 · 2025 $389

Food & beverage: $389
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation6$149
GlaxoSmithKline, LLC.3$83
PFIZER INC.3$73
Syndax Pharmaceuticals, Inc.1$25
Novocure Inc.1$24
Merck Sharp & Dohme LLC1$21
Stemline Therapeutics Inc.1$15

Products named: OJJAARA, SCEMBLIX, ELREXFIO, KISQALI, Fabhalta, Optune Lua (NovoTTF-200T), LUTATHERA, XTANDI.

Industry payments across OR — which companies pay providers there.